Esther Rodríguez1, Jaume Ferrer2, Sergi Martí2, Jan-Paul Zock3, Estel Plana3, Ferran Morell2. 1. Respiratory Medicine Department Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, CIBER Enfermedades Respiratorias, Barcelona, Spain. Electronic address: estherod@vhebron.net. 2. Respiratory Medicine Department Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, CIBER Enfermedades Respiratorias, Barcelona, Spain. 3. Centre for Research in Environmental Epidemiology CIBER Epidemiología y Salud Pública, Barcelona, Spain.
Abstract
BACKGROUND: The relationship between occupational exposures and COPD has been analyzed in population-based and occupational cohort studies. However, the influence of these exposures on the clinical characteristics of COPD is not well known. The aim of this study was to analyze the impact of occupational exposures on respiratory symptoms, lung function, and employment status in a series of COPD patients. METHODS: We conducted a cross-sectional study of 185 male COPD patients. Patients underwent baseline spirometry and answered a questionnaire that included information on respiratory symptoms, hospitalizations for COPD, smoking habits, current employment status, and lifetime occupational history. Exposure to biological dust, mineral dust, and gases and fumes was assessed using an ad hoc job exposure matrix. RESULTS: Having worked in a job with high exposure to mineral dust or to any dusts, gas, or fumes was associated with an FEV(1) of < 30% predicted (mineral dust: relative risk ratio, 11; 95% confidence interval [CI], 1.4 to 95; dusts, gas, or fumes: relative risk ratio, 6.9; 95% CI, 1.1 to 45). High exposure to biological dust was associated with chronic sputum production (odds ratio [OR], 4.3; 95% CI, 1.6 to 12), dyspnea (OR, 2.7; 95% CI, 1.1 to 6.7), and work inactivity (OR, 2.4; 95% CI, 1.4 to 4.2). High exposure to dusts, gas, or fumes was associated with sputum production (OR, 2.8; 95% CI, 1.2 to 6.7) and dyspnea (OR, 1.2; 95% CI, 1.1 to 1.4). CONCLUSIONS: Occupational exposures are independently associated with the severity of airflow limitation, respiratory symptoms, and work inactivity in patients with COPD.
BACKGROUND: The relationship between occupational exposures and COPD has been analyzed in population-based and occupational cohort studies. However, the influence of these exposures on the clinical characteristics of COPD is not well known. The aim of this study was to analyze the impact of occupational exposures on respiratory symptoms, lung function, and employment status in a series of COPDpatients. METHODS: We conducted a cross-sectional study of 185 male COPDpatients. Patients underwent baseline spirometry and answered a questionnaire that included information on respiratory symptoms, hospitalizations for COPD, smoking habits, current employment status, and lifetime occupational history. Exposure to biological dust, mineral dust, and gases and fumes was assessed using an ad hoc job exposure matrix. RESULTS: Having worked in a job with high exposure to mineral dust or to any dusts, gas, or fumes was associated with an FEV(1) of < 30% predicted (mineral dust: relative risk ratio, 11; 95% confidence interval [CI], 1.4 to 95; dusts, gas, or fumes: relative risk ratio, 6.9; 95% CI, 1.1 to 45). High exposure to biological dust was associated with chronic sputum production (odds ratio [OR], 4.3; 95% CI, 1.6 to 12), dyspnea (OR, 2.7; 95% CI, 1.1 to 6.7), and work inactivity (OR, 2.4; 95% CI, 1.4 to 4.2). High exposure to dusts, gas, or fumes was associated with sputum production (OR, 2.8; 95% CI, 1.2 to 6.7) and dyspnea (OR, 1.2; 95% CI, 1.1 to 1.4). CONCLUSIONS: Occupational exposures are independently associated with the severity of airflow limitation, respiratory symptoms, and work inactivity in patients with COPD.
Authors: Brent Doney; Eva Hnizdo; Monica Graziani; Greg Kullman; Cecil Burchfiel; Sherry Baron; Kaori Fujishiro; Paul Enright; John L Hankinson; Karen Hinckley Stukovsky; Christopher J Martin; Kathleen M Donohue; R Graham Barr Journal: COPD Date: 2014-02-25 Impact factor: 2.409
Authors: Laura M Paulin; Gregory B Diette; Paul D Blanc; Nirupama Putcha; Mark D Eisner; Richard E Kanner; Andrew J Belli; Stephanie Christenson; Donald P Tashkin; MeiLan Han; R Graham Barr; Nadia N Hansel Journal: Am J Respir Crit Care Med Date: 2015-03-01 Impact factor: 21.405
Authors: Nathaniel Marchetti; Eric Garshick; Gregory L Kinney; Alex McKenzie; Douglas Stinson; Sharon M Lutz; David A Lynch; Gerard J Criner; Edwin K Silverman; James D Crapo Journal: Am J Respir Crit Care Med Date: 2014-10-01 Impact factor: 21.405
Authors: I Guseva Canu; M Hemmendinger; J J Sauvain; G Suarez; N B Hopf; J A Pralong; T Ben Rayana; S Besançon; K Sakthithasan; V Jouannique; A Debatisse Journal: J Occup Med Toxicol Date: 2021-06-24 Impact factor: 2.646
Authors: Laura M Paulin; Benjamin M Smith; Abby Koch; MeiLan Han; Eric A Hoffman; Carlos Martinez; Chinedu Ejike; Paul D Blanc; Jennifer Rous; R Graham Barr; Stephen P Peters; Robert Paine; Cheryl Pirozzi; Christopher B Cooper; Mark T Dransfield; Alejandro P Comellas; Richard E Kanner; M Brad Drummond; Nirupama Putcha; Nadia N Hansel Journal: Ann Am Thorac Soc Date: 2018-12
Authors: Esther Rodríguez; Jaume Ferrer; Jan-Paul Zock; Ignasi Serra; Josep M Antó; Jordi de Batlle; Hans Kromhout; Roel Vermeulen; David Donaire-González; Marta Benet; Eva Balcells; Eduard Monsó; Angel Gayete; Judith Garcia-Aymerich Journal: PLoS One Date: 2014-02-06 Impact factor: 3.240